Ameritas Investment Partners, Inc. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$300,064
+84.5%
11,379
+20.3%
0.01%
+100.0%
Q2 2023$162,660
+19.6%
9,457
+15.3%
0.01%
+20.0%
Q1 2023$135,956
+94.6%
8,2000.0%0.01%
+66.7%
Q4 2022$69,864
-13.7%
8,2000.0%0.00%
-25.0%
Q3 2022$81,000
+9.5%
8,2000.0%0.00%
+33.3%
Q2 2022$74,000
-10.8%
8,2000.0%0.00%0.0%
Q1 2022$83,000
-39.4%
8,2000.0%0.00%
-40.0%
Q4 2021$137,000
-65.3%
8,200
-2.8%
0.01%
-64.3%
Q3 2021$395,000
-23.2%
8,4380.0%0.01%
-22.2%
Q2 2021$514,000
+9.1%
8,438
+10.3%
0.02%0.0%
Q1 2021$471,000
+6.8%
7,653
+23.3%
0.02%
-10.0%
Q4 2020$441,000
+89.3%
6,2060.0%0.02%
+81.8%
Q3 2020$233,000
+10.4%
6,206
-4.2%
0.01%
+10.0%
Q2 2020$211,000
+12.2%
6,4780.0%0.01%
-9.1%
Q1 2020$188,000
+184.8%
6,478
+244.9%
0.01%
+266.7%
Q4 2019$66,000
+65.0%
1,8780.0%0.00%
+50.0%
Q3 2019$40,0001,8780.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders